Viewing Study NCT02181218


Ignite Creation Date: 2025-12-25 @ 4:46 AM
Ignite Modification Date: 2026-03-01 @ 12:34 PM
Study NCT ID: NCT02181218
Status: COMPLETED
Last Update Posted: 2020-11-17
First Post: 2014-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
Sponsor:
Organization: